People

David Roblin

David Roblin

David Roblin is Chief Executive Officer of Relation, leading AI-assisted drug discovery and development. He previously led European R&D at Pfizer and held senior scientific-translation and executive roles at the Francis Crick Institute. The company appointed him CEO in June 2022.

Roles

Relation Therapeutics

Chief Executive Officer

Current
Current